Vanguard Group’s Entero Therapeutics ENTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $108K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $4.78K | Hold |
|
|||||
|
2023
Q2 | $26.4K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $227K | Sell |
|
|||||
|
2021
Q4 | $424K | Hold |
|
|||||
|
2021
Q3 | $825K | Hold |
|
|||||
|
2021
Q2 | $2.4M | Buy |
|
|||||
|
2021
Q1 | $1.44M | Buy |
|
|||||
|
2020
Q4 | $665K | Sell |
|
|||||
|
2020
Q3 | $521K | Buy |
|
|||||
|
2020
Q2 | $623K | Sell |
|
|||||
|
2020
Q1 | $405K | Hold |
|
|||||
|
2019
Q4 | $726K | Hold |
|
|||||
|
2019
Q3 | $419K | Buy |
|
|||||
|
2019
Q2 | $443K | Buy |
|
|||||
|
2019
Q1 | $177K | Hold |
|
|||||
|
2018
Q4 | $89K | Sell |
|
|||||
|
2018
Q3 | $1.06M | Hold |
|
|||||
|
2018
Q2 | $1.3M | Buy |
|
|||||
|
2018
Q1 | $357K | Hold |
|
|||||
|
2017
Q4 | $330K | Hold |
|
|||||
|
2017
Q3 | $328K | Buy |
|